Healthcare -
Biotechnology - NASDAQ - US
$ 42.01
-5.13 %
$ 2.58 B
Market Cap
9.93
P/E
PTGX - REVENUE
Revenue PTGX - Protagonist Therapeutics, Inc.
434 M
LAST VALUE
304.27%
2 YEAR CAGR
351.71%
5 YEAR CAGR
0.00%
10 YEAR CAGR